3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
2
Smoking Cessation
1
Neoplasms, Second Primary
1
Hand-Foot Syndrome
1
Cigarette Smoking
1
Chemotherapy-Related Cognitive Impairment
1
Behavior, Addictive
1
Interventions
Leucovorin
2
Irinotecan
2
Fluorouracil
2
dostarlimab
1
avelumab
1
Varenicline
1
Tobacco Use Cessation Devices
1
Temozolomide
1
Radiotherapy
1
Panitumumab
1
Nicotine Chewing Gum
1
Cetuximab
1
Bupropion
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Neoplasms, Second Primary
×
Tobacco Use Cessation Devices
×
Clear all
NCT04634071
2026-02-02
TTOP
University of Kentucky
Phase 2
Completed
126 enrolled